Feasibility of antiretroviral treatment monitoring in the era of decentralized HIV care: A systematic review

AIDS Research and Therapy

Volumn 14, Issue 1, 2017, Pages

  Pham, Minh D ^a,b   Romero, Lorena ^c   Parnell, Bruce ^a   Anderson, David A ^a,b   Crowe, Suzanne M ^a,b,c   Luchters, Stanley ^a,b,d  

^a BURNET INSTITUTE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c ALFRED HOSPITAL   (Australia)

^d GHENT UNIVERSITY   (Belgium)

Author keywords

Antiretroviral treatment; CD4; Decentralized care; HIV; Systematic review; Task shifting; Treatment monitoring; Viral load

Indexed keywords

ANTIRETROVIRUS AGENT; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

AFRICA SOUTH OF THE SAHARA; BLOOD SAMPLING; CD4 LYMPHOCYTE COUNT; DECENTRALIZATION; DRUG EFFICACY; FEASIBILITY STUDY; FOLLOW UP; HEALTH CARE ACCESS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT MONITORING; REVIEW; RURAL AREA; SYSTEMATIC REVIEW; VIRUS LOAD; DRUG MONITORING; HEALTH CARE DELIVERY; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS 1; ISOLATION AND PURIFICATION; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); VIROLOGY;

ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; DRUG MONITORING; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HIV-1; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VIRAL LOAD;

EID: 85009957667     PISSN: None     EISSN: 17426405     Source Type: Journal    
DOI: 10.1186/s12981-017-0131-5     Document Type: Review

References (51)

1. Sidibe M, Zuniga JM, Montaner J. Leveraging HIV treatment to end AIDS, stop new HIV infections, and avoid the cost of inaction. Clin Infect Dis. 2014;59(Suppl 1):S3-6.
2. UNAIDS. "15 by 15" a global target achieved. 2015. Joint United Nations Programme on HIV/AIDS: Geneva, 2015.
3. Scanlon ML, Vreeman RC. Current strategies for improving access and adherence to antiretroviral therapies in resource-limited settings. HIV AIDS. 2013;5:1-17.
4. Kredo T, et al. Task shifting from doctors to non-doctors for initiation and maintenance of antiretroviral therapy. Cochrane Database Syst Rev. 2014;7:CD007331.
5. Kredo T, et al. Decentralising HIV treatment in lower- and middle-income countries. Cochrane Database Syst Rev. 2013;6:CD009987.
6. Suthar AB, et al. Improving antiretroviral therapy scale-up and effectiveness through service integration and decentralization. Aids. 2014;28:S175-85.
7. WHO. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. Geneva: World Health Organization; 2015. p. 78.
8. WHO. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection recommendations for a public health approach. Geneva: World Health Organization; 2013. p. 272.
9. Crowley T, Stellenberg EL. Integrating HIV care and treatment into primary healthcare: are clinics equipped? Afr J Prim Health Care Fam Med. 2014;6(1):E1-7.
10. Sawe FK, McIntyre JA. Monitoring HIV antiretroviral therapy in resource-limited settings: time to avoid costly outcomes. Clin Infect Dis. 2009;49(3):463-5.
11. Moher D, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.
12. Walter J, et al. Treatment outcomes before and after the decentralization of art in an Urban setting in Mozambique. Top Antivir Med. 2014;22:555-6.
13. Fairall L, et al. Task shifting of antiretroviral treatment from doctors to primary-care nurses in South Africa (STRETCH): a pragmatic, parallel, cluster-randomised trial. Lancet. 2012;380(9845):889-98.
14. Selke HM, et al. Task-shifting of antiretroviral delivery from health care workers to persons living with HIV/AIDS: clinical outcomes of a community-based program in Kenya. J Acquir Immune Defic Syndr JAIDS. 2010;55(4):483-90.
15. Hansudewechakul R, et al. Successful clinical outcomes following decentralization of tertiary paediatric HIV care to a community-based paediatric antiretroviral treatment network, Chiangrai, Thailand, 2002 to 2008. J Int AIDS Soc. 2012;15(2):17358.
16. Brennan AT, et al. Outcomes of stable HIV-positive patients down-referred from a doctor-managed antiretroviral therapy clinic to a nurse-managed primary health clinic for monitoring and treatment. AIDS. 2011;25(16):2027-36.
17. Bedelu M, et al. Implementing antiretroviral therapy in rural communities: the Lusikisiki model of decentralized HIV/AIDS care. J Infect Dis. 2007;196(Suppl 3):S464-8.
18. Uzodike N, Ross A, Harbor O. Adherence by a primary healthcare clinic in KwaZulu-Natal to the national HIV guidelines. S Afr Fam Pract. 2015;57(3):198-202.
19. Boulle A, et al. Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa. AIDS. 2010;24(4):563-72.
20. Mutevedzi PC, et al. Scale-up of a decentralized HIV treatment programme in rural KwaZulu-Natal, South Africa: does rapid expansion affect patient outcomes? Bull World Health Organ. 2010;88(8):593-600.
21. Janssen N, et al. Successful paediatric HIV treatment in rural primary care in Africa. Arch Dis Child. 2010;95(6):414-21.
22. Rich ML, et al. Excellent clinical outcomes and high retention in care among adults in a community-based HIV treatment program in rural Rwanda. JAcquir Immune Defic Syndr JAIDS. 2012;59(3):e35-42.
23. Vogt F, et al. Access to CD4 testing for rural HIV patients: findings from a cohort study in Zimbabwe. PLoS ONE. 2015;10(6):e0129166.
24. Shumbusho F, et al. Task shifting for scale-up of HIV care: evaluation of nurse-centered antiretroviral treatment at rural health centers in Rwanda. PLoS Med. 2009;6(10):e1000163.
25. Sanne I, et al. Nurse versus doctor management of HIV-infected patients receiving antiretroviral therapy (CIPRA-SA): A randomised non-inferiority trial. Lancet. 2010;376(9734):33-40.
26. Jobanputra K, et al. Impact and programmatic implications of routine viral load monitoring in Swaziland. J Acquir Immune Defic Syndr. 2014;67(1):45-51.
27. Humphreys CP, et al. Nurse led, primary care based antiretroviral treatment versus hospital care: a controlled prospective study in Swaziland. BMC Health Serv Res. 2010;10:229.
28. Georgeu D, et al. Implementing nurse-initiated and managed antiretroviral treatment (NIMART) in South Africa: a qualitative process evaluation of the STRETCH trial. Implement Sci. 2012;7:66.
29. Labhardt ND, et al. Adoption of new HIV treatment guidelines and drug substitutions within first-line as a measure of quality of care in rural Lesotho: health centers and hospitals compared. Trop Med Int Health. 2012;17(10):1245-54.
30. Assefa Y, et al. Effectiveness and acceptability of delivery of antiretroviral treatment in health centres by health officers and nurses in Ethiopia. J Health Serv Res Policy. 2012;17(1):24-9.
31. Lecher S, et al. Scale-up of HIV viral load monitoring-seven sub-Saharan African countries. MMWR Morb Mortal Wkly Rep. 2015;64(46):1287-90.
32. Essajee S, Kumarasamy N. Commentary: the monitoring of adults and children on antiretroviral therapy in the 2013 WHO consolidated ARV guidelines. AIDS. 2014;28(Suppl 2):S147-9.
33. Rutstein SE, et al. On the front line of HIV virological monitoring: barriers and facilitators from a provider perspective in resource-limited settings. AIDS Care. 2016;28(1):1-10.
34. Jourdain G, et al. Switching HIV treatment in adults based on CD4 count versus viral load monitoring: a randomized, non-inferiority trial in Thailand. PLoS Med. 2013;10(8):e1001494.
35. Mermin J, et al. Utility of routine viral load, CD4 cell count, and clinical monitoring among adults with HIV receiving antiretroviral therapy in Uganda: randomised trial. BMJ. 2011;343:d6792.
36. Laurent C, et al. Monitoring of HIV viral loads, CD4 cell counts, and clinical assessments versus clinical monitoring alone for antiretroviral therapy in rural district hospitals in Cameroon (Stratall ANRS 12110/ESTHER): a randomised non-inferiority trial. Lancet Infect Dis. 2011;11(11):825-33.
37. Estill J, et al. Monitoring of antiretroviral therapy and mortality in HIV programmes in Malawi, South Africa and Zambia: mathematical modelling study. PLoS ONE. 2013;8(2):e57611.
38. Shen Z, et al. Effects of CD4 cell counts and viral load testing on mortality rates in patients with HIV infection receiving antiretroviral treatment: an observational cohort study in rural southwest China. Clin Infect Dis. 2016;63:108-14.
39. Roberts T, et al. Scale-up of routine viral load testing in resource-poor settings: current and future implementation challenges. Clin Infect Dis. 2016;62:1043-8.
40. WHO. The availability and use of HIV diagnostics: a 2012/2013 WHO survey in low- and middle-income countries. Geneva: World Health Organization; 2014. p. 29.
41. Fatti G, Grimwood A, Bock P. Better antiretroviral therapy outcomes at primary healthcare facilities: an evaluation of three tiers of ART services in four South African provinces. PLoS ONE. 2010;5(9):e12888.
42. Abaissa SG, et al. Adverse drug reactions associated with antiretroviral treatment among adult ethiopian patients in a tertiary hospital. Ethiop Med J. 2012;50(2):107-13.
43. Jima YT, Angamo MT, Wabe NT. Causes for antiretroviral regimen change among HIV/AIDS patients in Addis Ababa, Ethiopia. Tanzan J Health Res. 2013;15(1):11-8.
44. Berheto TM, Haile DB, Mohammed S. Predictors of loss to follow-up in patients living with HIV/AIDS after initiation of antiretroviral therapy. N Am J Med Sci. 2014;6(9):453-9.
45. Tupasi TE, et al. Factors associated with loss to follow-up during treatment for multidrug-resistant tuberculosis, the Philippines, 2012-2014. Emerg Infect Dis. 2016;22(3):491-502.
46. Scott LE, et al. A meta-analysis of the performance of the Pima CD4 for point of care testing. BMC Med. 2015;13:168.
47. Vojnov L, et al. POC CD4 testing improves linkage to HIV care and timeliness of ART initiation in a public health approach: a systematic review and meta-analysis. PLoS ONE. 2016;11(5):e0155256.
48. Kober K, Van Damme W. Scaling up access to antiretroviral treatment in southern Africa: who will do the job? Lancet. 2004;364(9428):103-7.
49. Mbewu AD. Changing history-closing the gap in AIDS treatment and prevention. Bull World Health Organ. 2004;82(6):400.
50. Johnston V, et al. Viral suppression following switch to second-line antiretroviral therapy: associations with nucleoside reverse transcriptase inhibitor resistance and subtherapeutic drug concentrations prior to switch. J Infect Dis. 2014;209(5):711-20.
51. Ramadhani HO, et al. Association of first-line and second-line antiretroviral therapy adherence. Open Forum Infect Dis. 2014;1(2):0fu079.